These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3606060

  • 1. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM, Malinverni R, Glauser MP.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [Abstract] [Full Text] [Related]

  • 2. Role of tolerance in cloxacillin prophylaxis of experimental Staphylococcus aureus endocarditis.
    Voorn GP, Thompson J, Goessens WH, Schmall-Bauer W, Broeders PH, Michel MF.
    J Infect Dis; 1992 Jul; 166(1):169-73. PubMed ID: 1607692
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J, López P, Martín T, Gomis X, Ramírez JL, Azuaje C, Almirante B, Pahissa A.
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L, Glauser MP, Bille J.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.
    Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A.
    Ann Intern Med; 1996 Dec 15; 125(12):969-74. PubMed ID: 8967707
    [Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May 15; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 7. Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat.
    Baumgartner JD, Glauser MP.
    J Antimicrob Chemother; 1983 Dec 15; 12 Suppl D():79-87. PubMed ID: 6583198
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
    Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF.
    J Antimicrob Chemother; 1994 Apr 15; 33(4):785-94. PubMed ID: 8056697
    [Abstract] [Full Text] [Related]

  • 9. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G, Valdés M, Pérez R, Martín-Luengo F, García A, Soria F, Gómez J.
    Enferm Infecc Microbiol Clin; 1991 Apr 15; 9(4):208-10. PubMed ID: 1830757
    [Abstract] [Full Text] [Related]

  • 10. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis.
    Voorn GP, Thompson J, Goessens WH, Schmal-Bauer W, Broeders PH, Michel MF.
    J Infect Dis; 1991 Mar 15; 163(3):640-3. PubMed ID: 1995736
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM, Georgopoulos A, Stanek G, Breyer S, Rotter ML.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar 15; 267(4):541-8. PubMed ID: 3164157
    [Abstract] [Full Text] [Related]

  • 12. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 2001 Nov 15; 45(11):3076-83. PubMed ID: 11600359
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P, Klastersky J.
    Drugs Exp Clin Res; 1986 Nov 15; 12(4):307-11. PubMed ID: 3013562
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1986 Sep 15; 30(3):382-4. PubMed ID: 3640590
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1989 Apr 15; 33(4):519-21. PubMed ID: 2499251
    [Abstract] [Full Text] [Related]

  • 16. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ, Valdés M, Martín-Luengo F, Arribas JP, Albaladejo J, Pérez-Gracia A, García-Henarejos JA, Martínez-Madrid O, García-Alberola A.
    Enferm Infecc Microbiol Clin; 1993 May 15; 11(5):235-40. PubMed ID: 8324018
    [Abstract] [Full Text] [Related]

  • 17. Paradoxical dose effect of continuously administered cloxacillin in treatment of tolerant Staphylococcus aureus endocarditis in rats.
    Voorn GP, Thompson J, Goessens WH, Schmal-Bauer WC, Broeders PH, Michel MF.
    J Antimicrob Chemother; 1994 Mar 15; 33(3):585-93. PubMed ID: 8040122
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Rose WE, Leonard SN, Rybak MJ.
    Antimicrob Agents Chemother; 2008 Sep 15; 52(9):3061-7. PubMed ID: 18591272
    [Abstract] [Full Text] [Related]

  • 19. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul 15; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 20. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.
    Antimicrob Agents Chemother; 1997 Aug 15; 41(8):1662-7. PubMed ID: 9257737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.